419 related articles for article (PubMed ID: 31402959)
1. Clinical value of microRNA-198-5p downregulation in lung adenocarcinoma and its potential pathways.
Wang SS; Fang YY; Huang JC; Liang YY; Guo YN; Pan LJ; Chen G
Oncol Lett; 2019 Sep; 18(3):2939-2954. PubMed ID: 31402959
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G
Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858
[TBL] [Abstract][Full Text] [Related]
3. Identification of a Potentially Functional microRNA-mRNA Regulatory Network in Lung Adenocarcinoma Using a Bioinformatics Analysis.
Wang XJ; Gao J; Wang Z; Yu Q
Front Cell Dev Biol; 2021; 9():641840. PubMed ID: 33681226
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis.
Li Y; Yu X; Zhang Y; Wang X; Zhao L; Liu D; Zhao G; Gao X; Fu J; Zang A; Jia Y
Biomed Eng Online; 2021 Nov; 20(1):117. PubMed ID: 34819106
[TBL] [Abstract][Full Text] [Related]
5. Clinical Significance of microRNA-196b-5p in Hepatocellular Carcinoma and its Potential Molecular Mechanism.
Zhang L; Luo B; Dang YW; He RQ; Peng ZG; Chen G; Feng ZB
J Cancer; 2019; 10(22):5355-5370. PubMed ID: 31632480
[No Abstract] [Full Text] [Related]
6. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
[TBL] [Abstract][Full Text] [Related]
7. Expression, Clinical Significance, Immune Infiltration, and Regulation Network of miR-3940-5p in Lung Adenocarcinoma Based on Bioinformatic Analysis and Experimental Validation.
Lin Z; Huang W; Xie Z; Yi Y; Li Z
Int J Gen Med; 2022; 15():6451-6464. PubMed ID: 35966511
[TBL] [Abstract][Full Text] [Related]
8. Clinical value of miR-145-5p in NSCLC and potential molecular mechanism exploration: A retrospective study based on GEO, qRT-PCR, and TCGA data.
Gan TQ; Xie ZC; Tang RX; Zhang TT; Li DY; Li ZY; Chen G
Tumour Biol; 2017 Mar; 39(3):1010428317691683. PubMed ID: 28347234
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of miR-302b-5p expression and molecular mechanism in hepatocellular carcinoma: Findings based on RT-qPCR and in silico analysis.
Wu HY; Cai KT; Ma J; Chen G; Dang YW; Lu HP; Pan SL
Pathol Res Pract; 2019 Jul; 215(7):152424. PubMed ID: 31103408
[TBL] [Abstract][Full Text] [Related]
10. Role of miR-452-5p in the tumorigenesis of prostate cancer: A study based on the Cancer Genome Atl(TCGA), Gene Expression Omnibus (GEO), and bioinformatics analysis.
Gao L; Zhang LJ; Li SH; Wei LL; Luo B; He RQ; Xia S
Pathol Res Pract; 2018 May; 214(5):732-749. PubMed ID: 29559248
[TBL] [Abstract][Full Text] [Related]
11. Potential clinical value and putative biological function of miR-122-5p in hepatocellular carcinoma: A comprehensive study using microarray and RNA sequencing data.
Wen DY; Huang JC; Wang JY; Pan WY; Zeng JH; Pang YY; Yang H
Oncol Lett; 2018 Dec; 16(6):6918-6929. PubMed ID: 30546424
[TBL] [Abstract][Full Text] [Related]
12. Clinical Value and Prospective Pathway Signaling of MicroRNA-375 in Lung Adenocarcinoma: A Study Based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and Bioinformatics Analysis.
Gan TQ; Chen WJ; Qin H; Huang SN; Yang LH; Fang YY; Pan LJ; Li ZY; Chen G
Med Sci Monit; 2017 May; 23():2453-2464. PubMed ID: 28533502
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation.
Luo J; Shi K; Yin SY; Tang RX; Chen WJ; Huang LZ; Gan TQ; Cai ZW; Chen G
World J Surg Oncol; 2018 Apr; 16(1):76. PubMed ID: 29636077
[TBL] [Abstract][Full Text] [Related]
14. The expression of HOXA13 in lung adenocarcinoma and its clinical significance: A study based on The Cancer Genome Atlas, Oncomine and reverse transcription-quantitative polymerase chain reaction.
Deng Y; He R; Zhang R; Gan B; Zhang Y; Chen G; Hu X
Oncol Lett; 2018 Jun; 15(6):8556-8572. PubMed ID: 29805592
[TBL] [Abstract][Full Text] [Related]
15. Identification of key genes in lung adenocarcinoma based on a competing endogenous RNA network.
Song Z; Zhang Y; Chen Z; Zhang B
Oncol Lett; 2021 Jan; 21(1):60. PubMed ID: 33281971
[TBL] [Abstract][Full Text] [Related]
16. Six MicroRNA Prognostic Models for Overall Survival of Lung Adenocarcinoma.
Li J; Gu X; Gao C; Zhang J
Genet Res (Camb); 2022; 2022():5955052. PubMed ID: 36101742
[TBL] [Abstract][Full Text] [Related]
17.
Wu C; Dong B; Huang L; Liu Y; Ye G; Li S; Qi Y
Front Oncol; 2021; 11():754290. PubMed ID: 34745988
[TBL] [Abstract][Full Text] [Related]
18. Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma.
Li W; Liu S; Su S; Chen Y; Sun G
PeerJ; 2021; 9():e10470. PubMed ID: 33510968
[TBL] [Abstract][Full Text] [Related]
19. Role of upregulated miR-136-5p in lung adenocarcinoma: A study of 1242 samples utilizing bioinformatics analysis.
Li TT; Gao X; Gao L; Gan BL; Xie ZC; Zeng JJ; Chen G
Pathol Res Pract; 2018 May; 214(5):750-766. PubMed ID: 29526559
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of miR-452-5p expression in lung adenocarcinoma: A retrospective quantitative real-time polymerase chain reaction study and verification based on The Cancer Genome Atlas and Gene Expression Omnibus databases.
Gan XN; Luo J; Tang RX; Wang HL; Zhou H; Qin H; Gan TQ; Chen G
Tumour Biol; 2017 May; 39(5):1010428317705755. PubMed ID: 28488527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
